FEATURED PRODUCTS

CTA AxCESS Protein Microarray | Sengenics | Krex Technology | Protein Microarray Supplier

IMMUNOME
Protein Array

High-throughput
sero-profiling platform

CTA AxCESS Protein Microarray | Sengenics | Krex Technology | Protein Microarray Supplier

CTA
Protein Array

Screening of
cancer-testis antigens

CTA AxCESS Protein Microarray | Sengenics | Krex Technology | Protein Microarray Supplier

OncoREX p53
Cancer Array

Cancer drug
screening and discovery

CTA AxCESS Protein Microarray | Sengenics | Krex Technology | Protein Microarray Supplier

Custom
Protein Array

Flexible format for
high-throughput screening

KREX TECHNOLOGY

KREX™ utilises the BCCP folding marker to actively select for soluble, correctly folded, functional proteins

PARTNERING

Engage in innovative research, discovery and development through active long-term collaborations with us

UPCOMING EVENTS

JANUARY 13 – 16, 2020

SUPPORT

Resources to access our technology

FAQs

Your technical questions - answered

APPLICATIONS

One technology - endless possibilities

Sengenics - Functional Proteomics | Krex Technology | Protein Microarray Supplier

Sengenics is a Functional Proteomics company that leverages its patented KREX technology to discover autoantibody biomarker signatures for prediction of drug response and severe immune-related adverse events (irAEs). KREX can also be used to identify autoantibody biomarkers to diagnose cancer, autoimmune, neurodegenerative or infectious diseases with higher sensitivity and specificity than conventional diagnostic tests. Some autoantibodies that are identified as diagnostic biomarkers may be protective and have potential in themselves as therapeutic biomolecules.

Copyright 2008 – 2021 Sengenics All rights reserved | Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics UK Registered in England and Wales no. 12889389

X